Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Corp. (EW) shares fell 2.47% to $91.33 on Thursday, underperforming the broader market and key competitors like Abbott, Medtronic, and Stryker. This marks the third consecutive day of losses for the stock, which closed 5.15% below its 52-week high. Trading volume reached 5.5 million, exceeding the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) shed 2.47% to $91.33 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.81% to 7,543.64 and the Dow Jones Industrial Average rising 0.27% to 52,487.41.
This was the stock's third consecutive day of losses.
Edwards Lifesciences Corp. closed 5.15% below its 52-week high of $96.29, which the company achieved on July 7th.
The stock underperformed when compared to some of its competitors Thursday, as Abbott Laboratories (ABT) fell 0.82% to $94.40, Medtronic PLC (MDT) rose 0.46% to $82.39, and Stryker Corp. (SYK) rose 0.08% to $327.11.
Trading volume (5.5 M) eclipsed its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-09-26 1647ET